Invention Grant
- Patent Title: Compositions and methods for immune cell modulation in adoptive immunotherapies
-
Application No.: US16466265Application Date: 2017-12-04
-
Publication No.: US11932870B2Publication Date: 2024-03-19
- Inventor: Jonathan Rosen , Betsy Denise Rezner , Ian Hardy , Eigen Peralta
- Applicant: Fate Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Fate Therapeutics, Inc.
- Current Assignee: Fate Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Greenberg Traurig, LLP
- International Application: PCT/US2017/064507 2017.12.04
- International Announcement: WO2018/106595A 2018.06.14
- Date entered country: 2019-06-03
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K35/17
Abstract:
Compounds that either produced a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
Public/Granted literature
- US20200181573A1 COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES Public/Granted day:2020-06-11
Information query
